Hyperparathyroidism causes bone loss leading to fractures, kidney stones, kidney damage, low energy, bone pain, sleep issues, irritability, and issues with memory and concentration, along with many other symptoms
Compared to DPP-4 inhibitors, GLP-1 receptor agonists have the potential for more robust A1C reductions (0.5% to 2.0%) and weight loss
These differences can impact the medications side effects, effectiveness, and cost factors that are essential to consider when choosing between the two
Personally I get nervous if I take more than 1,000 mg but the point is that it is a good drug in low doses but caution is warranted
The impact of endometriosis across the lifespan of women: foreseeable research and therapeutic prospects
How does the Precision Peptide Genetic Test improve my online GLP-1 selection